Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA approves Johnson & Johnson cataract treatment

December 4, 2019
Research and Development

Johnson & Johnson has secured approval from the FDA for its Tecnis Toris II 1-Piece Intraocular Lens (IOL).                                                                               &nbs

News
tecentriq

Roche’s Tecentriq combo scores FDA approval in non-small cell lung cancer

December 4, 2019
Research and Development, Sales and Marketing FDA, NSCLC, Roche, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atelizumab) has chalked up another approval from the FDA, this time in combination with the chemotherapy Abraxane …

News
920x920

Purdue Pharma’s Richard Sackler ignored OxyContin addiction concerns, new emails show

December 3, 2019
Manufacturing and Production, Sales and Marketing Opiod, Purdue Pharma, Richard Sackler, opiod crisis

A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew …

News
astrazeneca_plaque

AstraZeneca sells US/Canada rights for Seroquel for $41 million to “focus on main therapy areas”

December 3, 2019
Manufacturing and Production, Sales and Marketing AstraZeneca, pharma

AstraZeneca has announced its intention to jettison the rights to two non-core drugs in the US and Canada in order …

News
showimage

Jeremy Corbyn writes Trump letter asking for reassurance over NHS in trade deal

December 3, 2019
Manufacturing and Production Boris, Boris Johnson, Boris NHS, Jeremy Corbyn, Labour Party, NHS, Trump

Labour Party leader Jeremy Corbyn has written to US President Donald Trump demanding he confirm that he will not put …

News
ap_01101003057-1024x672

Reagan-era FDA Commissioner Frank Young dies

December 3, 2019
Manufacturing and Production FDA, FDA commissioner, Frank Young

Frank Young, FDA Commissioner from 1984-1989, died on 24 November. He was 88; his son, Jonathan, said the cause was …

News

Astellas poised to acquire neuromuscular disease specialist Audentes for $3bn all-cash

December 3, 2019
Manufacturing and Production, Sales and Marketing Astellas, Audentes, acquisition, neuromuscular disease, pharma

Astellas Pharma is set to acquire US-based Audentes Therapeutics in an all-cash deal valued at $3 billion in cash, it …

News

Dr Richard Torbett is named as the new Chief Executive of the ABPI

December 2, 2019
Sales and Marketing British pharmaceuticals, Dr Richard Corbett, apbi, appointments

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will …

News
sang-jin_pak

Exclusive interview: Samsung Bioepis’ Sang-Jin Pak on the rise of biosimilars

December 2, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung Bioepis, biosimilars, pharma

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel’s interview with Sang-Jin …

Feature
prison_bars_5997920696

FDA urged to investigate use of unapproved drug on prisoners

December 2, 2019
Sales and Marketing FDA, Opiods, US Opiods, opiod crisis

The Louisiana Department of Public Safety and Corrections (LDPSC) and BioCorRx Inc are alleged to have collaborated in testing an …

News

NICE authorises Lynparza for NHS use in all BRCA-mutated ovarian cancer cases

December 2, 2019
Sales and Marketing Cancer, NHS, NICE, lynparza, ovarian cancer, pharma

NICE has given its recommendation for the routine use on the NHS in England and Wales of AstraZeneca and MSD’s …

News
180921-drugs-pills-bottle-faeture-image

Labour and Lib Dems make election pledge for wider access to HIV drug

December 2, 2019
Sales and Marketing AIDS, Conservatives, HIV. HIV Drugs, Labour Party, Liberal Democrats, lib dems

The Labour Party and the Liberal Democrats have both pledged to roll out access to pre-exposure prophylaxis (PrEP) therapy for …

News

British pharmaceutical industry is threatened by Labour, says former Party health minister

December 2, 2019
Sales and Marketing British pharmaceuticals, Election 2019, Jeremy Corbyn, Labour Party, NHS

A former Labour Party health minister has said that the British pharmaceutical industry is “under threat” from a Jeremy Corbyn …

News

Roche’s satralizumab shows promise at Phase 3 in neuromyelitis optica spectrum disorder

December 2, 2019
Research and Development, Sales and Marketing Roche, pharma, satralizumab

Roche has presented new data on its interleukin-6 (IL-6) inhibitor satralizumab in the treatment of neuromyelitis optica spectrum disorder (NMOSD), …

News
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

November 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Jeremy Corbyn, NHS, Opiod, US, opiod crisis

The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which …

News
nhs_sign

Few in NHS trust tech firms handling patient data

November 29, 2019
Medical Communications AI, Boris, Corbyn, NHS, NHS Brexit, johnson

Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll …

News
26682732344_ae569bf0e3_b

Immupharma and Avion sign agreement for lupus drug Lupuzor

November 29, 2019
Medical Communications Diseases, Lupus, Lupuzor, avion

Immupharma has signed a development agreement with Avion Pharmaceuticals to acquire the licensing rights for Lupuzor, a peptide therapeutic and …

News
indian_pharma

Study shows widespread bribery in Indian pharmaceutical industry

November 29, 2019
Medical Communications India, Indian Pharma, Modi, bribery

A recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes …

News

FDA gives priority review for AstraZeneca’s Imfinzi

November 29, 2019
Medical Communications AstraZeneca, Cancer, FDA, Imfinzi, lung cancer

The FDA has granted a priority review of AstraZeneca’s cancer treatment drug Imfinzi (durvalumab) for treatment of patients with untreated …

News
merck-keytruda

Prostate Cancer ‘super responders’ could live for two more years on Keytruda

November 28, 2019
Research and Development Cancer, immunotherapy, keytruda, oncology, prostate cancer

Men with advanced prostate cancer, who have exhausted all treatment options, could use the immunotherapy Keytruda (pembrolizumab) to live for …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026